Emma Ito, Ph.D.
Affiliations: | 2010 | Medical Biophysics | University of Toronto, Toronto, ON, Canada |
Area:
Oncology, Medical BiophysicsGoogle:
"Emma Ito"Mean distance: (not calculated yet)
Parents
Sign in to add mentorFei-Fei Liu | grad student | 2010 | University of Toronto | |
(High-throughput screening for novel anti-cancer radiosensitizers for head and neck cancer.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Cheung R, Ito E, Lopez M, et al. (2022) Evaluating the Short-Term Environmental and Clinical Effects of a Radiation Oncology Department's Response to the COVID-19 Pandemic (STEER COVID-19). International Journal of Radiation Oncology, Biology, Physics |
Harnett N, Tosoni S, Brandt C, et al. (2021) Accelerated Education Program in Radiation Medicine: International Learner Perceptions of Experiences, Outcomes, and Impact. International Journal of Radiation Oncology, Biology, Physics. 109: 656-660 |
Ito E, Moraes FY, Ramotar M, et al. (2020) Radiation Oncology Fellowship: a Value-Based Assessment Among Graduates of a Mature Program. Journal of Cancer Education : the Official Journal of the American Association For Cancer Education |
Bruce JP, Yip K, Bratman SV, et al. (2015) Nasopharyngeal Cancer: Molecular Landscape. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology |
Williams JP, Kim I, Ito E, et al. (2014) Pre-clinical characterization of Dacomitinib (PF-00299804), an irreversible pan-ErbB inhibitor, combined with ionizing radiation for head and neck squamous cell carcinoma. Plos One. 9: e98557 |
Lenarduzzi M, Hui AB, Yue S, et al. (2013) Hemochromatosis enhances tumor progression via upregulation of intracellular iron in head and neck cancer. Plos One. 8: e74075 |
Ito E, Yue S, Moriyama EH, et al. (2013) Targeting uroporphyrinogen decarboxylase for head and neck cancer treatment Bmc Proceedings. 7 |
P'ng C, Ito E, How C, et al. (2012) Excellence in Radiation Research for the 21st Century (EIRR21): description of an innovative research training program. International Journal of Radiation Oncology, Biology, Physics. 83: e563-70 |
Williams JP, Kim I, Yue S, et al. (2012) Abstract 2879: Pre-clinical characterization of Dacomitinib, an irreversible pan-HER inhibitor, combined with radiation therapy in head and neck cancer models Cancer Research. 72: 2879-2879 |
Hui A, How C, Ito E, et al. (2011) Micro-RNAs as diagnostic or prognostic markers in human epithelial malignancies. Bmc Cancer. 11: 500 |